RVPH Reviva Pharmaceuticals

Watchlist

Trading May 22 14:13 ET

41.04MMarket Cap-924P/E (TTM)

Reviva Pharmaceuticals Stock Analyst Ratings & Price Target

Updated: May 16, 2024

Based on 2 analysts giving stock ratings to Reviva Pharmaceuticals in the past 3 months

Buy

Updated: May 16, 2024

The average Reviva Pharmaceuticals stock price target is 20.00 with a max estimate of 20.00 and a min estimate of 20.00

Review Reviva Pharmaceuticals earnings estimates

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Updated: May 16, 2024

Buy

Updated: May 16, 2024

Overall